statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LAKE FOREST, Ill., April 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ( Assertio or the Company ) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...

Sig Kirk Joins Assertio Board of Directors

LAKE FOREST, Ill., April 01, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ( Assertio or the Company ) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...

Assertio to Present at LD Micro Invitational Conference in New York City

NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Assertio Holdings, Inc...

ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Q4 2023 Assertio Holdings Inc Earnings Call Transcript

Net Sales Dip but Cash Flow Remains Positive; Company Sets 2024 Guidance for GrowthRelated Stocks: ASRT...

Assertio Holdings Inc (ASRT) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results

Fourth Quarter Net Product Sales $32.5 Million, Cash Flow from Operations of $5.7 Million 2024 Full Year Outlook for Net Product Sales of $110 to $125 Million...

Assertio Reports Fourth Quarter and Full Year 2023 Financial Results

Assertio Holdings's Earnings: A Preview

NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Assertio Holdings, Inc. ("Assertio Holdings" or the "Company") (NASDAQ: ASRT) of a class action securities...

March 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ASRT

LOS ANGELES, March 05, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...

DEADLINE ALERT for ASRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 04, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Assertio Holdings, Inc...

Assertio Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Volume	305,683.00
52-Wk High	$8.01
52-Wk Low	$0.7324

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.03	--	--	N/A
Q4'23	$0.00	$0.11	100.00%	BEAT
Q3'23	$0.10	$0.01	-89.47%	MISSED
Q2'23	$0.19	$0.19	2.33%	BEAT
Q1'23	$0.18	$0.29	60.22%	BEAT

ASRT Assertio Holdings Inc

About

Feed

News

Sentiment

Earnings

Fundamentals